Biostax Corp.
Biostax Corp. operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products. Its lead investigational drug candidate Lodonal, an once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Its programs also include Global Telehealth platform; Medtech asset,… Read more
Biostax Corp. (BTAX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.000x
Based on the latest financial reports, Biostax Corp. (BTAX) has a cash flow conversion efficiency ratio of 0.000x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($49.00) by net assets ($-5.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biostax Corp. - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Biostax Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biostax Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biostax Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wiltrom Co., Ltd.
TWO:6767
|
N/A |
|
PowerUp Acquisition Corp. Warrant
NASDAQ:PWUPW
|
0.282x |
|
Mahmood Textile Mills Ltd
KAR:MEHT
|
N/A |
|
Kodal Minerals PLC
LSE:KOD
|
0.000x |
|
Kukyoung G&M
KO:006050
|
-0.032x |
|
Nexa Resources Peru S.A.A.
LIM:NEXAPEC1
|
N/A |
|
N.W.F Group
LSE:NWF
|
0.102x |
|
Voyager Digital Ltd
PINK:VYGVQ
|
-0.047x |
Annual Cash Flow Conversion Efficiency for Biostax Corp. (2019–2023)
The table below shows the annual cash flow conversion efficiency of Biostax Corp. from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-4.53 Million | $-408.03K | 0.090x | -61.07% |
| 2022-12-31 | $-2.51 Million | $-581.82K | 0.231x | +694.02% |
| 2021-12-31 | $-7.95 Million | $-231.72K | 0.029x | +77.19% |
| 2020-12-31 | $-11.67 Million | $-191.96K | 0.016x | +24013.14% |
| 2019-12-31 | $-13.69 Million | $-934.00 | 0.000x | -- |